Others investigated how complement interacts with the platelet-induced-NETs–thrombin axis during COVID-19 and found increased plasma levels of NETs, tissue factor (TF) activity and sC5b-9 in COVID-19 patients [85]. The gene discussed is F3; the disease is COVID-19.